Axonics gains after win in trial in patent dispute with Medtronic [Seeking Alpha]
Axonics, Inc. (AXNX)
Last axonics, inc. earnings: 3/4 04:01 pm
Check Earnings Report
Company Research
Source: Seeking Alpha
Medtronic ( MDT ) was seeking $150 million in a patent dispute with Axonics ( AXNX ), thought it was awarded nothing from a jury in Central District of California court on Wednesday. "Medtronic respectfully disagrees with the jury's verdict and will file post-trial motions, and an appeal, if necessary, to overturn this verdict," Medtronic said in a statement emailed to Seeking Alpha. "Additionally, Medtronic will continue fighting to protect and enforce its intellectual property rights with a pending case against Axonics at the International Trade Commission." The court decision comes after The Patent Trial and Appeal Board of the U.S. Patent and Trademark Office affirmed as valid claims for two Medtronic MDT ) patents related to sacral neuromodulation technologies in an ongoing lawsuit against Axonics ( AXNX ) in March. In late February, Axonics ( AXNX ) said Medtronic ( MDT filed a complaint with the U.S. International Trade Commission and the U.S. District Court in Delaware
Show less
Read more
Impact Snapshot
Event Time:
AXNX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AXNX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AXNX alerts
High impacting Axonics, Inc. news events
Weekly update
A roundup of the hottest topics
AXNX
News
- Axonics, Inc. (NASDAQ: AXNX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.MarketBeat
- Axonics Reports Third Quarter 2024 Financial ResultsBusiness Wire
- Axonics Shares Fall Despite Australia's Approval for R20 SNM Device [Yahoo! Finance]Yahoo! Finance
- Axonics' sacral neuromodulation device cleared in Australia [Yahoo! Finance]Yahoo! Finance
- Axonics Receives Regulatory Approval for Fourth-Generation Rechargeable SNM System in AustraliaBusiness Wire
AXNX
Earnings
- 11/7/24 - Miss
AXNX
Sec Filings
- 11/7/24 - Form 10-Q
- 11/7/24 - Form 8-K
- 10/3/24 - Form 4
- AXNX's page on the SEC website